InsiderClue

Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 1/25
RXST
Result 28 decisions over 120 months
Reset filters
Direction ?
Both28 Bought8 Sold20
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo 120 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Company: RXST Plan: Discretionary
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
RXST RxSight, Inc.
2 Sep 2026
Wilterding Mark
Chief Financial Officer
Sold at will
7,765
$54.04K
23.7%
RXST RxSight, Inc.
2 Sep 2026
Kurtz Ronald M MD
Chief Medical Officer
Sold at will
5,100
$35.50K
6.6%
RXST RxSight, Inc.
2 Sep 2026
Weinberg Eric
See remarks
Sold at will
2,041
$14.21K
1.0%
RXST RxSight, Inc.
2 Sep 2026
Goldshleger Ilya
Chief Operating Officer
Sold at will
2,041
$14.21K
2.4%
RXST RxSight, Inc.
16 Jan 2025
Corley Jesse Anderson
Director indirect
Bought
1,767
$55.00K
122%
RXST RxSight, Inc.
15 Jan 2025
Corley Jesse Anderson
Director indirect
Bought
1,443
$45.00K
opened
RXST RxSight, Inc.
13 Nov 2024
Corley Jesse Anderson
Director
Bought 2×
5,795
$259.84K
17.8%
RXST RxSight, Inc.
13 Nov 2024
Corley Jesse Anderson
Director indirect
Bought
5,570
$250.65K
1.2%
RXST RxSight, Inc.
12 Nov 2024
Corley Jesse Anderson
Director indirect
Bought
11,111
$504.08K
2.4%
RXST RxSight, Inc.
17 May 2024
Tammenoms Bakker Juliet
Director
Bought
5,000
$305.46K
16.8%
RXST RxSight, Inc.
14 Feb 2024
Tammenoms Bakker Juliet
Director
Bought
4,000
$205.15K
15.5%
RXST RxSight, Inc.
12 Feb 2024
Tammenoms Bakker Juliet
Director
Bought
4,000
$201.52K
18.3%
RXST RxSight, Inc.
6 Feb 2024
Thunen Shelley B
Chief Financial Officer
Sold at will
15,875
$753.57K
53.7%
RXST RxSight, Inc.
5 Feb 2024
Thunen Shelley B
Chief Financial Officer
Sold at will
9,125
$429.09K
40.0%
RXST RxSight, Inc.
1 Feb 2024
LINK WILLIAM J PHD
Director indirect
Sold at will 2×
28,250
$1.40M
53.8%
RXST RxSight, Inc.
26 Jan 2024
Thunen Shelley B
Chief Financial Officer
Sold at will
31,772
$1.50M
82.4%
RXST RxSight, Inc.
22 Dec 2023
Goldshleger Ilya
Chief Operating Officer
Sold at will
5,000
$200.00K
15.9%
RXST RxSight, Inc.
22 Dec 2023
Weinberg Eric
Chief Commercial Officer indirect
Sold at will
1,285
$51.40K
0.4%
RXST RxSight, Inc.
29 Nov 2023
Tammenoms Bakker Juliet
Director indirect
Sold at will
349,245
$10.40M
100%
RXST RxSight, Inc.
28 Nov 2023
Tammenoms Bakker Juliet
Director indirect
Sold at will
145,068
$4.30M
29.3%
RXST RxSight, Inc.
15 Nov 2023
Tammenoms Bakker Juliet
Director indirect
Sold at will
400,000
$10.88M
44.7%
RXST RxSight, Inc.
14 Nov 2023
Tammenoms Bakker Juliet
Director indirect
Sold at will
100,000
$2.71M
10.1%
RXST RxSight, Inc.
11 Sep 2023
Tammenoms Bakker Juliet
Director
Sold at will
2,950
$88.52K
12.7%
RXST RxSight, Inc.
8 Sep 2023
Tammenoms Bakker Juliet
Director
Sold at will
10,033
$303.46K
30.2%
RXST RxSight, Inc.
7 Sep 2023
Tammenoms Bakker Juliet
Director
Sold at will
19,967
$600.98K
37.6%
RXST RxSight, Inc.
25 Aug 2023
Tammenoms Bakker Juliet
Director
Sold at will
16,208
$474.13K
23.4%
RXST RxSight, Inc.
18 Aug 2023
Tammenoms Bakker Juliet
Director
Sold at will
14,651
$425.88K
17.6%
RXST RxSight, Inc.
17 Aug 2023
Tammenoms Bakker Juliet
Director
Sold at will
18,484
$555.69K
18.2%
Showing 1–28 of 28.